Regentis Biomaterials Ltd... (RGNT)
NYSE American: RGNT
· リアルタイム株価 · USD
2.06
-0.17 (-7.62%)
終値時点: Aug 20, 2026, 3:59 PM
株価、主要な数字、最新ニュースをひとまとめにしたページです。
Regentis Biomaterials Ltd.(RGNT)の株価・分析・データ
-7.62% (1D)
RGNTについて
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the ...
セクター Healthcare
IPO日 Dec 4, 2025
従業員数 n/a
上場取引所 NYSE American
ティッカー RGNT
ウェブサイト https://www.regentis.co.il
